We need to mandate drug cost transparency on electronic medical records
- 17 December 2017
- journal article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 189 (50), E1541-E1542
- https://doi.org/10.1503/cmaj.171070
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Potential savings from therapeutic substitution of 10 of Canada’s most dispensed prescription drugsPublished by Informa UK Limited ,2018
- Out-of-pocket costs and adherence to antihypertensive agents among older adults covered by the public drug insurance plan in QuebecPatient Preference and Adherence, 2017
- Giving formulary and drug cost information to providers and impact on medication cost and use: a longitudinal non-randomized studyBMC Health Services Research, 2016
- Effect of Electronic Prescribing With Formulary Decision Support on Medication Use and CostArchives of Internal Medicine, 2008
- “Breakthrough” drugs and growth in expenditure on prescription drugs in CanadaBMJ, 2005
- Physicians' Attitudes About Prescribing and Knowledge of the Costs of Common MedicationsArchives of Internal Medicine, 2000
- Drug Prices and Third Party PaymentPharmacoEconomics, 1994